Appili Therapeutics Stock Performance

APLIF Stock  USD 0.02  0  14.29%   
On a scale of 0 to 100, Appili Therapeutics holds a performance score of 3. The firm shows a Beta (market volatility) of -0.0074, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Appili Therapeutics are expected to decrease at a much lower rate. During the bear market, Appili Therapeutics is likely to outperform the market. Please check Appili Therapeutics' downside variance, rate of daily change, and the relationship between the maximum drawdown and skewness , to make a quick decision on whether Appili Therapeutics' price patterns will revert.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Appili Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile forward indicators, Appili Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow11.1 M
Total Cashflows From Investing Activities5.1 M
  

Appili Therapeutics Relative Risk vs. Return Landscape

If you would invest  1.60  in Appili Therapeutics on November 11, 2025 and sell it today you would earn a total of  0.00  from holding Appili Therapeutics or generate 0.0% return on investment over 90 days. Appili Therapeutics is currently producing 0.3252% returns and takes up 8.2037% volatility of returns over 90 trading days. Put another way, 73% of traded pink sheets are less volatile than Appili, and 94% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Appili Therapeutics is expected to generate 10.25 times more return on investment than the market. However, the company is 10.25 times more volatile than its market benchmark. It trades about 0.04 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

Appili Therapeutics Target Price Odds to finish over Current Price

The tendency of Appili Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.02 90 days 0.02 
about 70.89
Based on a normal probability distribution, the odds of Appili Therapeutics to move above the current price in 90 days from now is about 70.89 (This Appili Therapeutics probability density function shows the probability of Appili Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Appili Therapeutics has a beta of -0.0074. This suggests as returns on the benchmark increase, returns on holding Appili Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Appili Therapeutics is likely to outperform the market. Additionally Appili Therapeutics has an alpha of 0.19, implying that it can generate a 0.19 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Appili Therapeutics Price Density   
       Price  

Predictive Modules for Appili Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Appili Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.028.22
Details
Intrinsic
Valuation
LowRealHigh
0.000.018.21
Details

Appili Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Appili Therapeutics is not an exception. The market had few large corrections towards the Appili Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Appili Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Appili Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.19
β
Beta against Dow Jones-0.0074
σ
Overall volatility
0
Ir
Information ratio 0.01

Appili Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Appili Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Appili Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Appili Therapeutics had very high historical volatility over the last 90 days
Appili Therapeutics has some characteristics of a very speculative penny stock
Appili Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 1.39 M. Net Loss for the year was (25.12 M) with profit before overhead, payroll, taxes, and interest of 1.39 M.
Appili Therapeutics has accumulated about 5.55 M in cash with (19.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 12.0% of the company shares are held by company insiders

Appili Therapeutics Fundamentals Growth

Appili Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Appili Therapeutics, and Appili Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Appili Pink Sheet performance.

About Appili Therapeutics Performance

By analyzing Appili Therapeutics' fundamental ratios, stakeholders can gain valuable insights into Appili Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Appili Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Appili Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada. Appili Therapeutics is traded on OTC Exchange in the United States.

Things to note about Appili Therapeutics performance evaluation

Checking the ongoing alerts about Appili Therapeutics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Appili Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Appili Therapeutics had very high historical volatility over the last 90 days
Appili Therapeutics has some characteristics of a very speculative penny stock
Appili Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 1.39 M. Net Loss for the year was (25.12 M) with profit before overhead, payroll, taxes, and interest of 1.39 M.
Appili Therapeutics has accumulated about 5.55 M in cash with (19.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 12.0% of the company shares are held by company insiders
Evaluating Appili Therapeutics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Appili Therapeutics' pink sheet performance include:
  • Analyzing Appili Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Appili Therapeutics' stock is overvalued or undervalued compared to its peers.
  • Examining Appili Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Appili Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Appili Therapeutics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Appili Therapeutics' pink sheet. These opinions can provide insight into Appili Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Appili Therapeutics' pink sheet performance is not an exact science, and many factors can impact Appili Therapeutics' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Appili Pink Sheet analysis

When running Appili Therapeutics' price analysis, check to measure Appili Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Appili Therapeutics is operating at the current time. Most of Appili Therapeutics' value examination focuses on studying past and present price action to predict the probability of Appili Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Appili Therapeutics' price. Additionally, you may evaluate how the addition of Appili Therapeutics to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites